查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1957835

2026年全球皮下给药装置市场报告

Subcutaneous Drug Delivery Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，皮下给药装置的市场规模显着成长。预计该市场将从2025年的297.7亿美元成长到2026年的320.3亿美元，复合年增长率（CAGR）为7.6%。过去几年的成长归因于多种因素，例如糖尿病和慢性病盛行率的上升、胰岛素笔和笔针使用量的增加、医院和诊所基础设施的扩建、先进给药技术的应用有限以及人们对皮下给药认识的提高。

预计未来几年皮下给药装置市场将维持强劲成长，2030年市场规模将达到424.2亿美元，复合年增长率（CAGR）为7.3%。预测期内的成长要素包括生物製药和肿瘤治疗的拓展、智慧自动注射器的普及、居家医疗环境的扩展、植入式帮浦技术的进步以及对以患者为中心的给药解决方案日益增长的需求。预测期内的主要趋势包括自动注射器和智慧注射装置的普及、对家庭和自我管理疗法的偏好日益增强、对微创给药方法的需求不断增长、生物製药和生物类似药给药应用的拓展，以及透过人性化装置设计提高患者依从性。

预计未来几年，糖尿病和心血管疾病（CVD）盛行率的不断上升将推动皮下给药装置市场的扩张。导致糖尿病和心血管疾病发生率上升的因素包括人口老化、不良饮食习惯、久坐的生活方式、肥胖、社会经济差距、压力、环境因素以及预防性医疗保健服务取得受限。皮下给药装置广泛应用于糖尿病管理（用于注射胰岛素和其他药物以控制血糖）和心血管护理（用于注射抗凝血剂和降脂药等药物），为长期疾病的管理提供了一种便捷且可控的方法。例如，根据美国疾病管制与预防中心（CDC）的数据，截至2024年10月，2023年心血管疾病导致919,032人死亡，约占总死亡人数的三分之一。因此，糖尿病和心血管疾病负担的加重正在推动皮下给药装置市场的成长。

皮下给药装置市场的主要企业正致力于开发先进技术，例如微型数位液体流量感测器，以实现大容量注射器的精确可自订流量控制，从而提高皮下给药的准确性和安全性。微型数位液体流量感测器是一种紧凑型组件，可在小规模应用中精确测量液体流量，并提供数位输出以进行精确监控和控制。例如，2024年5月，瑞士环境和流量感测器解决方案供应商Sensirion AG发布了SLD3x系列感测器平台。此产品线包含高精度数位液体流量感测器，具有可定製配置，提供精确流量测量、堵塞检测、在线连续气泡检测和液体温度监测等功能。这些紧凑型感测器非常适合大规模医疗设备生产，有助于提高皮下给药的剂量控制精度和病患安全性。

目录

第一章：执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球皮下给药装置市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单：主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章：全球市场趋势与策略

  • 关键科技与未来趋势
    • 生物技术、基因组学和精准医疗
    • 数位化、云端运算、巨量资料、网路安全
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施、互联生态系统
    • 工业4.0和智慧製造
  • 主要趋势
    • 自动注射器和智慧注射装置的应用日益普及
    • 人们越来越倾向于选择居家和自我治疗方式
    • 对微创药物传递方法的需求日益增长
    • 拓展生物製药和生物类似药製剂的药物传递应用
    • 透过人性化的设备设计提高患者依从性

第五章 终端用户产业市场分析

  • 医院和诊所
  • 居家医疗设施
  • 门诊手术中心
  • 专业医疗中心
  • 诊断和治疗中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及 COVID-19 疫情对市场的影响。

第七章：全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球皮下给药装置市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球皮下给药装置市场规模、对比及成长率分析
  • 全球皮下给药装置市场表现：规模与成长，2020-2025年
  • 全球皮下给药装置市场预测：规模与成长，2025-2030年，2035年预测

第八章：全球市场总规模（TAM）

第九章 市场细分

  • 依产品类型
  • 胰岛素笔、笔针、注射笔、自动注射器、植入式泵
  • 透过使用
  • 糖尿病、不孕症治疗、肿瘤学
  • 最终用户
  • 医院和诊所、居家医疗环境、门诊手术中心
  • 按类型细分：胰岛素笔
  • 抛弃式胰岛素笔，可重覆使用胰岛素笔
  • 按类型细分：针头式註射器
  • 标准注射笔针，安全注射笔针
  • 按类型细分：注射笔
  • 一次性注射笔，可重复使用注射笔
  • 按类型细分：自动注射器
  • 手动自动注射器，智慧型自动注射器
  • 按类型细分：嵌入式泵
  • 胰岛素泵，药物输注泵

第十章 区域与国别分析

  • 全球皮下给药装置市场：依地区划分，历史资料及预测，2020-2025年，2025-2030年预测，2035年预测
  • 全球皮下给药装置市场：依国家划分，实际值及预测值，2020-2025年、2025-2030年预测值、2035年预测值

第十一章 亚太市场

第十二章：中国市场

第十三章：印度市场

第十四章：日本市场

第十五章：澳洲市场

第十六章：印尼市场

第十七章：韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第20章 西欧市场

第21章英国市场

第22章：德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章：东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第三十章：加拿大市场

第31章：南美市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第三十五章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 皮下给药装置市场：竞争格局及市占率（2024年）
  • 皮下给药装置市场：公司估值矩阵
  • 皮下给药装置市场：公司概况
    • Pfizer Inc.
    • Sanofi SA
    • Roche Holdings Inc.
    • Medtronic plc
    • Eli Lilly and Company

第37章 其他大型企业和创新企业

  • Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc.

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年皮下给药装置市场：提供新机会的国家
  • 2030年皮下给药装置市场：充满新机会的细分市场
  • 皮下给药装置市场2030年：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第41章附录

简介目录
Product Code: PH6MSDDD01_G26Q1

Subcutaneous drug delivery devices are medical instruments developed to deliver medications directly into the subcutaneous tissue, which is the layer of fat and connective tissue located just beneath the skin. These devices are commonly used to administer a range of medications, including insulin, hormones, and biologics, offering a convenient and minimally invasive approach to drug delivery.

The primary product types of subcutaneous drug delivery devices include insulin pens, pen needles, injector pens, auto-injectors, and implantable pumps. Insulin pens are portable devices designed for the accurate and convenient delivery of insulin in diabetes care, enabling users to easily measure and inject prescribed doses. These devices are applied in various therapeutic areas such as diabetes, fertility, and oncology, and are used by multiple end users including hospitals and clinics, homecare settings, and ambulatory surgical centers.

Tariffs have impacted the subcutaneous drug delivery devices market by increasing the cost of imported components such as precision needles, electronic modules, and medical-grade plastics. Product segments including smart auto-injectors and implantable pumps are most affected, particularly in Asia-Pacific and Europe where manufacturing relies on cross-border supply chains. These cost pressures have led to higher device prices and delayed adoption in some regions. However, tariffs have also encouraged local manufacturing, supply chain diversification, and innovation in cost-effective subcutaneous delivery technologies.

The subcutaneous drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides subcutaneous drug delivery devices market statistics, including subcutaneous drug delivery devices industry global market size, regional shares, competitors with a subcutaneous drug delivery devices market share, detailed subcutaneous drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the subcutaneous drug delivery devices industry. This subcutaneous drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The subcutaneous drug delivery devices market size has grown strongly in recent years. It will grow from $29.77 billion in 2025 to $32.03 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising prevalence of diabetes and chronic diseases, increasing use of insulin pens and pen needles, growing hospital and clinic infrastructure, limited availability of advanced delivery technologies, increasing awareness of subcutaneous drug administration.

The subcutaneous drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $42.42 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to growth in biologics and oncology therapies, increasing adoption of smart auto-injectors, expansion of homecare settings, technological advancements in implantable pumps, rising demand for patient-centric drug delivery solutions. Major trends in the forecast period include rising adoption of auto-injectors and smart injection devices, growing preference for home-based and self-administration therapies, increasing demand for minimally invasive drug delivery methods, expansion of biologic and biosimilar drug delivery applications, improved patient compliance through user-friendly device designs.

The growing prevalence of diabetes and cardiovascular diseases (CVD) is expected to drive the expansion of the subcutaneous drug delivery devices market in the coming years. The rise in diabetes and cardiovascular conditions is influenced by factors such as aging populations, poor dietary habits, sedentary lifestyles, obesity, socioeconomic disparities, stress, environmental influences, and limited access to preventive healthcare services. Subcutaneous drug delivery devices are widely used in diabetes management to administer insulin and other therapies for glycemic control, and in cardiovascular care to deliver medications such as anticoagulants or lipid-lowering agents, offering a convenient and controlled approach to managing these long-term conditions. For example, in October 2024, according to the Centers for Disease Control and Prevention, a US-based federal agency, cardiovascular disease accounted for 919,032 deaths in 2023, representing nearly one in every three deaths. Consequently, the increasing burden of diabetes and cardiovascular diseases is contributing to the growth of the subcutaneous drug delivery devices market.

Major companies operating in the subcutaneous drug delivery devices market are concentrating on the development of advanced technologies, such as miniature digital liquid flow sensors, to improve the accuracy and safety of subcutaneous drug administration by enabling precise and customizable flow control for large-volume injectors. Miniature digital liquid flow sensors are compact components that accurately measure liquid flow rates in small-scale applications and provide digital outputs for precise monitoring and regulation. For instance, in May 2024, Sensirion AG, a Switzerland-based provider of environmental and flow sensor solutions, introduced the SLD3x series sensor platform. This product line includes highly accurate digital liquid flow sensors with customizable configurations, offering features such as precise flow measurement, occlusion detection, in-line air bubble detection, and liquid temperature monitoring. These compact sensors are well suited for large-scale medical device manufacturing, supporting accurate dosing and enhanced patient safety in subcutaneous drug delivery.

In November 2025, Halozyme Therapeutics, a US-based biopharmaceutical company focused on innovative drug delivery technologies, completed the acquisition of Elektrofi for an undisclosed amount. Through this acquisition, Halozyme seeks to broaden its drug delivery technology portfolio, strengthen its capabilities in developing high-concentration, ready-to-use injectable biologics, and reinforce its position in the rapidly expanding market for patient-friendly subcutaneous delivery solutions. Elektrofi is a US-based biotechnology company that specializes in subcutaneous drug delivery devices.

Major companies operating in the subcutaneous drug delivery devices market are Pfizer Inc., Sanofi S.A., Roche Holdings Inc., Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc., Unilife Corporation, PharmaJet, Oval Medical Technologies Ltd.

North America was the largest region in the subcutaneous drug delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the subcutaneous drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the subcutaneous drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The subcutaneous drug delivery devices market consists of sales of needles, cartridges, and reservoirs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Subcutaneous Drug Delivery Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses subcutaneous drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for subcutaneous drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The subcutaneous drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Insulin Pens; Pen Needles; Injector Pens; Auto-Injectors; Implantable Pumps
  • 2) By Application: Diabetes; Fertility; Oncology
  • 3) By End-User: Hospitals And Clinics; Homecare Settings; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Insulin Pens: Disposable Insulin Pens; Reusable Insulin Pens
  • 2) By Pen Needles: Standard Pen Needles; Safety Pen Needles
  • 3) By Injector Pens: Disposable Injector Pens; Reusable Injector Pens
  • 4) By Auto-Injectors: Manual Auto-Injectors; Smart Auto-Injectors
  • 5) By Implantable Pumps: Insulin Pumps; Drug Infusion Pumps
  • Companies Mentioned: Pfizer Inc.; Sanofi S.A.; Roche Holdings Inc.; Medtronic plc; Eli Lilly and Company; Amgen Inc.; Novo Nordisk A/S; Becton Dickinson and Company; West Pharmaceutical Services Inc.; Gerresheimer AG; Insulet Corporation; SHL Medical AG; Tandem Diabetes Care Inc.; Ypsomed Holding AG; Nemera; Elcam Medical Ltd.; Owen Mumford Ltd.; Haselmeier GmbH; Sensile Medical AG; Enable Injections Inc.; Unilife Corporation; PharmaJet; Oval Medical Technologies Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Subcutaneous Drug Delivery Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Subcutaneous Drug Delivery Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Subcutaneous Drug Delivery Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Subcutaneous Drug Delivery Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Auto-Injectors And Smart Injection Devices
    • 4.2.2 Growing Preference For Home-Based And Self-Administration Therapies
    • 4.2.3 Increasing Demand For Minimally Invasive Drug Delivery Methods
    • 4.2.4 Expansion Of Biologic And Biosimilar Drug Delivery Applications
    • 4.2.5 Improved Patient Compliance Through User-Friendly Device Designs

5. Subcutaneous Drug Delivery Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Homecare Settings
  • 5.3 Ambulatory Surgical Centers
  • 5.4 Specialty Care Centers
  • 5.5 Diagnostic And Treatment Centers

6. Subcutaneous Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Subcutaneous Drug Delivery Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Subcutaneous Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Subcutaneous Drug Delivery Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Subcutaneous Drug Delivery Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Subcutaneous Drug Delivery Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Subcutaneous Drug Delivery Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Subcutaneous Drug Delivery Devices Market Segmentation

  • 9.1. Global Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Insulin Pens, Pen Needles, Injector Pens, Auto-Injectors, Implantable Pumps
  • 9.2. Global Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diabetes, Fertility, Oncology
  • 9.3. Global Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers
  • 9.4. Global Subcutaneous Drug Delivery Devices Market, Sub-Segmentation Of Insulin Pens, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Disposable Insulin Pens, Reusable Insulin Pens
  • 9.5. Global Subcutaneous Drug Delivery Devices Market, Sub-Segmentation Of Pen Needles, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Standard Pen Needles, Safety Pen Needles
  • 9.6. Global Subcutaneous Drug Delivery Devices Market, Sub-Segmentation Of Injector Pens, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Disposable Injector Pens, Reusable Injector Pens
  • 9.7. Global Subcutaneous Drug Delivery Devices Market, Sub-Segmentation Of Auto-Injectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Manual Auto-Injectors, Smart Auto-Injectors
  • 9.8. Global Subcutaneous Drug Delivery Devices Market, Sub-Segmentation Of Implantable Pumps, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Insulin Pumps, Drug Infusion Pumps

10. Subcutaneous Drug Delivery Devices Market Regional And Country Analysis

  • 10.1. Global Subcutaneous Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Subcutaneous Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Subcutaneous Drug Delivery Devices Market

  • 11.1. Asia-Pacific Subcutaneous Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Subcutaneous Drug Delivery Devices Market

  • 12.1. China Subcutaneous Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Subcutaneous Drug Delivery Devices Market

  • 13.1. India Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Subcutaneous Drug Delivery Devices Market

  • 14.1. Japan Subcutaneous Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Subcutaneous Drug Delivery Devices Market

  • 15.1. Australia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Subcutaneous Drug Delivery Devices Market

  • 16.1. Indonesia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Subcutaneous Drug Delivery Devices Market

  • 17.1. South Korea Subcutaneous Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Subcutaneous Drug Delivery Devices Market

  • 18.1. Taiwan Subcutaneous Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Subcutaneous Drug Delivery Devices Market

  • 19.1. South East Asia Subcutaneous Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Subcutaneous Drug Delivery Devices Market

  • 20.1. Western Europe Subcutaneous Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Subcutaneous Drug Delivery Devices Market

  • 21.1. UK Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Subcutaneous Drug Delivery Devices Market

  • 22.1. Germany Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Subcutaneous Drug Delivery Devices Market

  • 23.1. France Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Subcutaneous Drug Delivery Devices Market

  • 24.1. Italy Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Subcutaneous Drug Delivery Devices Market

  • 25.1. Spain Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Subcutaneous Drug Delivery Devices Market

  • 26.1. Eastern Europe Subcutaneous Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Subcutaneous Drug Delivery Devices Market

  • 27.1. Russia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Subcutaneous Drug Delivery Devices Market

  • 28.1. North America Subcutaneous Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Subcutaneous Drug Delivery Devices Market

  • 29.1. USA Subcutaneous Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Subcutaneous Drug Delivery Devices Market

  • 30.1. Canada Subcutaneous Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Subcutaneous Drug Delivery Devices Market

  • 31.1. South America Subcutaneous Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Subcutaneous Drug Delivery Devices Market

  • 32.1. Brazil Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Subcutaneous Drug Delivery Devices Market

  • 33.1. Middle East Subcutaneous Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Subcutaneous Drug Delivery Devices Market

  • 34.1. Africa Subcutaneous Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Subcutaneous Drug Delivery Devices Market Regulatory and Investment Landscape

36. Subcutaneous Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 36.1. Subcutaneous Drug Delivery Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Subcutaneous Drug Delivery Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Subcutaneous Drug Delivery Devices Market Company Profiles
    • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Roche Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

37. Subcutaneous Drug Delivery Devices Market Other Major And Innovative Companies

  • Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc.

38. Global Subcutaneous Drug Delivery Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Subcutaneous Drug Delivery Devices Market

40. Subcutaneous Drug Delivery Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Subcutaneous Drug Delivery Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Subcutaneous Drug Delivery Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Subcutaneous Drug Delivery Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer